Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd., a Cayman Islands exempted company, filed this Form 6-K for the month of January 2025. The filing reports on the closing of a partial exercise of an over-allotment option related to its initial public offering (IPO).
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The only specific financial metric disclosed is the gross proceeds from the over-allotment exercise:
- Gross Proceeds from Over-Allotment: $697,612
- Shares Sold in Over-Allotment: 174,403 Ordinary Shares
- Offering Price: $4.00 per share
Material Changes
The primary material event reported is the partial exercise of the 45-day over-allotment option granted to underwriters on December 26, 2024. On January 22, 2025, the underwriters elected to purchase an additional 174,403 shares, with the transaction closing on January 24, 2025. This follows the initial sale of 1,200,000 ordinary shares in the firm commitment underwritten IPO.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, or specific risk factors beyond the standard disclosure of the underwriting agreement terms. No unusual items or contingencies are detailed in this specific report.
Investor Verification Checklist
- Verify the total net proceeds after deducting underwriting discounts and offering expenses, as only gross proceeds ($697,612) are stated.
- Confirm the total number of shares outstanding post-IPO and post-over-allotment exercise.
- Review the full underwriting agreement for details on lock-up periods and indemnification clauses.
- Check subsequent filings for the company's use of proceeds and updated liquidity position.